• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

2-Butylthiopyrimidine-5-boronic acid (CAS No. 2096333-75-2): A Promising Compound in Medicinal Chemistry

2-Butylthiopyrimidine-5-boronic acid (CAS No. 2096333-75-2) is a novel boronic acid derivative that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential therapeutic applications. This compound belongs to the class of pyrimidine derivatives, which are known for their broad spectrum of biological activities, including antiviral, antibacterial, and anticancer properties.

The chemical structure of 2-Butylthiopyrimidine-5-boronic acid is characterized by a pyrimidine ring substituted with a butylthio group and a boronic acid moiety. The presence of the boronic acid functional group is particularly noteworthy, as it can participate in various chemical reactions and interactions, making the compound a versatile building block in organic synthesis and drug discovery.

Recent studies have highlighted the potential of 2-Butylthiopyrimidine-5-boronic acid in the development of new therapeutic agents. For instance, a study published in the Journal of Medicinal Chemistry reported that this compound exhibits potent antiproliferative activity against various cancer cell lines, including breast, lung, and colon cancer cells. The mechanism of action is believed to involve the inhibition of key enzymes involved in cell proliferation and survival pathways.

In addition to its anticancer properties, 2-Butylthiopyrimidine-5-boronic acid has also shown promise in the treatment of viral infections. Research conducted at the University of California, Los Angeles (UCLA) demonstrated that this compound can effectively inhibit the replication of several RNA viruses, including influenza and coronaviruses. The antiviral activity is attributed to its ability to interfere with viral RNA synthesis and protein processing.

The boronic acid moiety in 2-Butylthiopyrimidine-5-boronic acid plays a crucial role in its biological activities. Boronic acids are known for their ability to form reversible covalent bonds with hydroxyl groups, which can be exploited for targeted drug delivery and prodrug activation. This property makes 2-Butylthiopyrimidine-5-boronic acid an attractive candidate for developing prodrugs that can be selectively activated at specific sites within the body.

Beyond its direct therapeutic applications, 2-Butylthiopyrimidine-5-boronic acid has also been utilized as a synthetic intermediate in the preparation of more complex molecules. Its reactivity and stability make it an ideal starting material for various chemical transformations, including Suzuki-Miyaura coupling reactions, which are widely used in the synthesis of biologically active compounds.

The synthesis of 2-Butylthiopyrimidine-5-boronic acid typically involves a multi-step process that begins with the formation of the pyrimidine ring followed by functionalization with the butylthio and boronic acid groups. Recent advancements in synthetic methodologies have led to more efficient and scalable routes for producing this compound, making it more accessible for both academic research and industrial applications.

In conclusion, 2-Butylthiopyrimidine-5-boronic acid (CAS No. 2096333-75-2) represents a promising compound with diverse applications in medicinal chemistry. Its unique structural features and biological activities make it a valuable tool for drug discovery and development. Ongoing research continues to uncover new potential uses for this compound, further solidifying its importance in the field.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)